Masanori Kai

926 citations
31 papers · 632 indexed · h-index 14
Topics
Mycobacterium research and diagnosis (21 papers)Leprosy Research and Treatment (17 papers)Tuberculosis Research and Epidemiology (9 papers)

In The Last Decade

Masanori Kai

31 papers receiving 613 citations

Peers

Masanori Kai
Comparison fields: 5 of 62
  • Infectious Diseases 402
  • Epidemiology 351
  • Surgery 216
  • Molecular Biology 154
  • Immunology 98
Replace Raymond P. Podzorski with:
Raymond P. Podzorski United States
María Verónica Bianco Argentina
Federico Carlos Blanco Argentina
Ludmila Naumann Germany
S K Furney United States
A Y Tsang United States
Yoon Hoh Kook South Korea
Samuel Yaw Aboagye Ghana
Wises Namwat Thailand
Petra Selchow Switzerland
Masanori Kai relative to Raymond P. Podzorski United States Raymond P. Podzorski's profile →
Citations per field
00.5×5.6×
Raymond P. Podzorski · 1×
Citations per year

Countries citing papers authored by Masanori Kai

Since Specialization
Citations

This map shows the geographic impact of Masanori Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Kai more than expected).

Fields of papers citing papers by Masanori Kai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanori Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Kai. The network helps show where Masanori Kai may publish in the future.

Co-authorship network of co-authors of Masanori Kai

This figure shows the co-authorship network connecting the top 25 collaborators of Masanori Kai. A scholar is included among the top collaborators of Masanori Kai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanori Kai. Masanori Kai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 10
3 17
4 21
5 6
6 12
7 26
8 8
9 5
10 8
11 10
12 19
13 33
14 5
15 23
16 120
17 61
18 28
19 52
20 26

About Masanori Kai

Masanori Kai is a scholar working on Infectious Diseases, Epidemiology and Pharmacology, having authored 31 papers that have together received 632 indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (21 papers), Leprosy Research and Treatment (17 papers) and Tuberculosis Research and Epidemiology (9 papers). The work is most often cited by research in Infectious Diseases (402 citations), Epidemiology (351 citations) and Small Animals (56 citations). Masanori Kai has collaborated with scholars based in Japan, United States and Myanmar. Frequent co-authors include Noboru Nakata, Yumi Maeda, Masahiko Makino, Masanori Matsuoka, Yoshiko Kashiwabara, Ken Hashimoto, Tetsu Mukai, Shinji Maeda, Hiroyuki Yamaguchi and Shigeru Kamiya. Their work appears in journals such as PLoS ONE, FEBS Letters and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026